While both subclones consistently maintained the same TERT promoter mutation (C250T) of the original tumor and cell line, subclone #11 showed higher enzymatic activity of telomerase and TERT expression compared with subclone #5 (Fig. 2a, 2b). The gene discussed is TERT; the disease is neoplasm.